"HER3 Mutations Affect Tumor Response to HER2-Targeted Therapies."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

HER3 missense mutations can inhibit response of tumor cells to HER2-targeted therapies. Click to show full abstract

HER3 missense mutations can inhibit response of tumor cells to HER2-targeted therapies.

Keywords: response; her2 targeted; her3 mutations; targeted therapies; tumor; mutations affect

Journal Title: Cancer discovery
Year Published: 2021

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended